| Gene symbol | CLDN18 | Synonyms | SFTA5, SFTPJ | Type of gene | protein-coding | |
| Chromosome | 3 | Map location | 3q22.3 | dbXrefs | Entrez:51208 MIM:609210 HGNC:HGNC:2039 Ensembl:ENSG00000066405 AllianceGenome:HGNC:2039 | |
| Gene perturbation-related omics dataset | PerturbAtlas | PertOrg | |||||
| Description | claudin 18 | |||||
| GTO ID | GTC2732 |
| Trial ID | NCT04966143 |
| Disease | Pancreatic Cancer |
| Altered gene | CLDN18 |
| Therapeutic/Target gene | Target gene |
| Therapy | CAR-T cell |
| Treatment | LY011 |
| Phase | Early_Phase1 |
| Recruitment status | Recruiting |
| Title | Clinical Study of LY011 in the Treatment of Advanced Pancreatic Cancer |
| Year | 2021 |
| Country | China |
| Company sponsor | Shanghai Longyao Biotechnology Inc., Ltd. |
| Other ID(s) | LY011C1001 |
| Cohort 1 | |||||||
|
|||||||